Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • November 7th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of October 14, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Amy Peterson (“Employee”).
SEPARATION AGREEMENTSeparation Agreement • November 7th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Separation Agreement (the “Agreement”) by and between Rachel Humphrey, M.D. (“Executive”), and CytomX Therapeutics, Inc., a Delaware corporation (the “Company”), is made effective as of the eighth (8th) day following the date Executive signs this Agreement if not revoked in accordance with Section 5(c)(iii) (the “Effective Date”) with reference to the following facts:
CONSULTING AGREEMENTConsulting Agreement • November 7th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Consulting Agreement (the “Agreement”) is made and entered into by and between CytomX Therapeutics, Inc., a Delaware corporation, with an address at 151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080, (“Company”) and Dr. Rachel Humphrey, an individual residing at 251 Bouvant Drive, Princeton, NJ 08540 (“Consultant”), effective as of August 19, 2019 (“Effective Date”).
